Adding immune-boosting agent to personalized cancer vaccine supercharges the body’s immune defense against malignant brain tumors

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.